Inder Verma
Inder Verma | |
|---|---|
| Born | Inder Mohan Verma 28 November 1947 Sangrur, Punjab, India |
| Alma mater | Lucknow University Massachusetts Institute of Technology Weizmann Institute of Science |
| Known for | Cancer, gene therapy, NF-kB |
| Awards | Member of the National Academy of Sciences (1997) EMBO Member (1998) |
| Scientific career | |
| Fields | Molecular Biology |
| Institutions | Salk Institute for Biological Studies |
| Academic advisors | David Baltimore |
Inder Mohan Verma (born 28 November 1947) is an Indian American molecular biologist, the former Cancer Society Professor of Molecular Biology in the Laboratory of Genetics at the Salk Institute for Biological Studies and the University of California, San Diego, and former editor-in-chief of the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS). He is recognized for seminal discoveries in the fields of cancer, immunology, and gene therapy.
Verma was accused of gender discrimination and decades-long sexual harassment by eleven women in lawsuits filed in 2017 and 2018. He resigned as editor-in-chief of PNAS in May 2018, and resigned his position at the Salk Institute in June 2018, before the board of trustees of the institute could take action regarding the allegations.